Active ingredient
Azacitidine
28 finished FDA listings contain Azacitidine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- AZACITIDINE
- Dosage forms
- Injection, Powder, Lyophilized, For Solution, Tablet, Film Coated
- Routes
- Intravenous, Oral, Subcutaneous
- Manufacturers / labelers
- 21
- Strengths listed
- 100 mg/1 · 100 mg/30ml · 100 mg/4ml · 100 mg/50ml · 200 mg/1 · 300 mg/1
- Brand names in FDA listings
- Azacitidine, Azacitidine Azacitidine, Onureg, Vidaza
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1251
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 050794 | BRISTOL-MYERS | 2004-05-19 | 1 |
| ANDA 201537 | DR REDDYS | 2013-09-16 | 5 |
| NDA 208216 | ACTAVIS LLC | 2016-04-29 | 1 |
| ANDA 207518 | ADAPTIS | 2016-09-29 | 4 |
| ANDA 207234 | NATCO PHARMA LTD | 2017-06-23 | 1 |
| ANDA 207475 | ACCORD HLTHCARE | 2018-07-02 | 2 |
| ANDA 209337 | EUROHLTH INTL SARL | 2020-06-08 | 1 |
| NDA 214120 | BRISTOL | 2020-09-01 | 2 |
| ANDA 212128 | MEITHEAL | 2020-11-02 | 2 |
| ANDA 211549 | AMNEAL | 2022-02-03 | 1 |
| ANDA 215066 | EUGIA PHARMA | 2022-12-30 | 1 |
| ANDA 215905 | JIANGSU HANSOH PHARM | 2023-06-28 | 1 |
| ANDA 212580 | MSN LABS PVT LTD | 2024-05-16 | 3 |
| ANDA 215765 | HETERO LABS LTD VI | 2024-10-15 | 1 |
| ANDA 217453 | RELIANCE LIFE | 2025-05-20 | 2 |
Official labeling on DailyMed
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP] · version 6 · 2026-09-10
- ONUREG (AZACITIDINE) TABLET, FILM COATED [CELGENE CORPORATION] · version 14 · 2026-06-15
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BLUEPOINT LABORATORIES.] · version 3 · 2026-03-30
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [DR. REDDY'S LABORATORIES INC.] · version 23 · 2026-02-26
- AZACITIDINE (AZACITIDINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SOMERSET THERAPEUTICS LLC] · version 2 · 2025-09-01
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CIVICA, INC.] · version 3 · 2025-08-26
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ARMAS PHARMACEUTICALS INC.] · version 4 · 2025-08-11
- AZACITIDINE (AZACITIDINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [RELIANCE LIFE SCIENCES PRIVATE LIMITED] · version 1 · 2025-07-31
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC.] · version 8 · 2025-07-28
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC.] · version 4 · 2025-07-25
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] · version 6 · 2025-07-10
- AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MSN LABORATORIES PRIVATE LIMITED] · version 2 · 2025-06-02
Showing the 12 most recent of 27 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.